Over the past few years, GLP-1 receptor agonists such as Mounjaro (tirzepatide) and Ozempic (semaglutide) have transformed diabetes and obesity care worldwide. These medications are often called “game changers” because of their dual benefits — controlling blood sugar and supporting weight reduction, with added protection for the heart.

However, with this popularity has come a wave of myths, misconceptions, and misinformation. Many patients today arrive at consultations influenced more by social media chatter than by sound medical advice. To provide clarity, Dr. Bhawna Attri, an eminent endocrinologist trained at the prestigious AIIMS New Delhi and a specialist in metabolic disorders, helps us separate fact from fiction.

What Are GLP-1 Receptor Agonists?

GLP-1 (glucagon-like peptide-1) is a natural hormone that helps regulate blood sugar by stimulating insulin release, slowing stomach emptying, and reducing appetite. GLP-1 receptor agonists mimic this hormone, offering better glucose control and sustainable weight loss.

Ozempic works on the GLP-1 pathway, while Mounjaro acts on both GLP-1 and GIP receptors, giving it an added advantage in weight management. These medications are given as weekly injections and have demonstrated significant benefits for both diabetic and non-diabetic patients with obesity or metabolic health concerns.

Myths vs Facts About GLP-1 Therapies

• Myth 1: These are “weight loss injections.”
  Fact: Originally developed for type 2 diabetes, their primary role is blood sugar control. Weight loss is an important but secondary benefit.

• Myth 2: Anyone can safely take these medicines.
  Fact: Not all patients are suitable. Those with certain thyroid conditions, pancreatitis, or genetic risks must avoid them. Only a qualified endocrinologist can assess suitability.

• Myth 3: You can stop once weight loss is achieved.
  Fact: These are long-term therapies. Stopping suddenly can cause weight regain or poor glucose control.

• Myth 4: Medicines replace lifestyle changes.
  Fact: GLP-1 therapies work best when combined with healthy eating, exercise, sleep, and behavioral support.

Why Expert Guidance Matters

At Moolchand Hospital, patient care under Dr. Bhawna Attri is rooted in five values: Superb endocrinologists, Cutting-edge technology, Compassionate care, Integrity, and Affordable prices.

Dr. Attri carefully evaluates each patient’s medical history, lifestyle, and health goals before recommending GLP-1 therapy. Her approach ensures:

• Proper screening to identify safe candidates

• Personalized dosing and monitoring of side effects

• Integrated care with diet, exercise, and emotional support

• Sustainable, long-term outcomes instead of quick fixes

Looking Ahead

Research continues to reveal new benefits of GLP-1 therapies — including roles in heart disease prevention, fatty liver management, and possibly even brain health. These are not fad treatments but a cornerstone of modern endocrine care.

Final Word

At Moolchand, patients considering Mounjaro or Ozempic are not just prescribed an injection. They receive comprehensive, compassionate, and science-based care led by Dr. Bhawna Attri.

If you are exploring GLP-1 therapy, trust Moolchand’s promise of Superb endocrinologists, Cutting-edge technology, Compassionate care, Integrity, and Affordable prices.

For appointments with Dr. Bhawna Attri, visit Moolchand Hospital and begin your journey toward healthier, sustainable living.